Your browser doesn't support javascript.
loading
miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
Zhang, Hui; Lang, Ting-Yuan; Zou, Dong-Ling; Zhou, Lei; Lou, Meng; Liu, Jing-Shu; Li, Yun-Zhe; Ding, Dong-Yan; Li, Yu-Cong; Zhang, Na; Zheng, Xiao-Dong; Zeng, Xiao-Hua; Zhou, Qi; Li, Li.
Afiliación
  • Zhang H; Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, Guangxi, People's Republic of China.
  • Lang TY; Breast Cancer Center, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
  • Zou DL; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
  • Zhou L; Key Laboratory for Biorheological Science and Technology of Ministry of Education (Chongqing University), Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, Chongqing, 400030, People's Republic of China.
  • Lou M; Department of Gynecologic Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
  • Liu JS; Department of Gynecologic Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
  • Li YZ; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Ding DY; Singapore Eye Research Institute, Singapore 169856, Singapore.
  • Li YC; Ophthalmology and Visual Sciences Academic Clinical Research Program, Duke-NUS Medical School, Singapore 169867, Singapore.
  • Zhang N; Department of Gynecologic Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
  • Zheng XD; Bioengineering College of Chongqing University, Chongqing University, Chongqing 400030, Chongqing, People's Republic of China.
  • Zeng XH; Bioengineering College of Chongqing University, Chongqing University, Chongqing 400030, Chongqing, People's Republic of China.
  • Zhou Q; Bioengineering College of Chongqing University, Chongqing University, Chongqing 400030, Chongqing, People's Republic of China.
  • Li L; Department of Gynecologic Oncology, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing 400030, Chongqing, People's Republic of China.
Onco Targets Ther ; 12: 11691-11700, 2019.
Article en En | MEDLINE | ID: mdl-32021247

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article